A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery—the first predictive biomarker ...
Sep 28, 2025
0
38
Scientific evidence supporting the health benefits of male circumcision—surgical removal of the foreskin from the penis—dates back hundreds of years to observations made by physicians of their circumcised patients. More recently, ...
Sep 15, 2025
1
37
Our genitals are such an important and sensitive part of our bodies. So it's not surprising that keeping them healthy was as important in antiquity as it is today.
Oct 13, 2025
0
37
A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with advanced disease.
Dec 19, 2025
0
35
A review in Clinical Epigenetics synthesizes growing evidence that paternal lifestyle and environmental exposures such as diet, obesity, smoking, endocrine-disrupting chemicals, and stress alter sperm epigenetic marks (DNA ...
Oct 17, 2025
0
35
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos Vargas, a Mayo Clinic radiation ...
Jul 28, 2025
0
34
Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way ...
Nov 10, 2025
0
31
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease worsening compared with ...
Sep 28, 2025
0
31
A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell Medicine, University ...
Jul 31, 2025
0
30
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University improves upon traditional methods of targeting bladder cancer cells with messenger RNA (mRNA) therapies.
Jan 18, 2026
0
30
